Check this page regularly for the latest news about the Parkinson's Foundation.
In the News
For the first time, the Parkinson's Foundation is openly talking about the use of medical marijuana for Parkinson's disease (PD).
Morning fun run in the East Bay saw hundreds of super heroes brave the rain and cold to help raise money for those affected by Parkinson's. All proceeds from the run will go to the Parkinson's Foundation Moving Day event.
On March 6 and 7, the Parkinson's Foundation will host its first-ever conference on medical marijuana in Denver. The conference will address potential risks and benefits of treating Parkinson's disease with medical cannabis by bringing together a diverse group of experts from academia, clinics, industry, government and the Parkinson's community to establish a consensus on medical marijuana use in Parkinson’s disease.
Sales of direct-to-consumer genetic tests are booming, but users should understand the possible implications of taking one and consult a medical professional about the results. James Beck, PhD, Parkinson's Foundation Chief Scientific Officer, is quoted.
The number of people living with Parkinson's worldwide could double in the next two decades, experts project. Study authors include multiple neurologists from Centers of Excellence: Michael S. Okun, MD, Ray Dorsey, MD, and Bastiaan R. Bloem, MD. Parkinson’s Foundation cited.
After Mindy McIlroy received her Parkinson’s diagnosis four years ago, she was afraid to tell her employer. Terranova, and her industry peers, responded with overwhelming support. Parkinson’s Foundation mentioned, as Mindy serves on our Board.
A PD diagnosis is associated with greater Medicare costs and out-of-pocket spending, according to a population-based Parkinson’s Foundation study. The Parkinson’s Foundation study is explained and John L. Lehr, CEO, and James Beck, PhD, the Foundation’s chief scientific officer, is quoted.
People with Parkinson’s generally experience a longer hospital stay than those entering the hospital for the same diagnosis without PD, and can develop more complications. This article cites Parkinson’s Outcomes Project data and promotes the Foundation’s Aware in Care kit as an “excellent resource for patients with PD who are going to the hospital.”
The most potent drug available for Parkinson's, levodopa, treats symptoms of the disease, but does not ease or increase its still-mysterious underlying causes, a new clinical trial has concluded. Dr. Michael S. Okun, Parkinson’s Foundation national medical director, is quoted.
Organizations and non-profits funded millions of dollars in neurogenerative disease research in 2018. The Parkinson’s Foundation is highlighted for its $6.2 million research grant investment.